189 related articles for article (PubMed ID: 34247191)
21. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations.
Kosfeld A; Brand F; Weiss AC; Kreuzer M; Goerk M; Martens H; Schubert S; Schäfer AK; Riehmer V; Hennies I; Bräsen JH; Pape L; Amann K; Krogvold L; Bjerre A; Daniel C; Kispert A; Haffner D; Weber RG
Hum Mol Genet; 2017 May; 26(9):1716-1731. PubMed ID: 28334964
[TBL] [Abstract][Full Text] [Related]
23. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
Fairlie WD; Uboldi AD; McCoubrie JE; Wang CC; Lee EF; Yao S; De Souza DP; Mifsud S; Metcalf D; Nicola NA; Norton RS; Baca M
J Biol Chem; 2004 Jan; 279(3):2125-34. PubMed ID: 14585833
[TBL] [Abstract][Full Text] [Related]
24. Cytoplasmic domains of the leukemia inhibitory factor receptor required for STAT3 activation, differentiation, and growth arrest of myeloid leukemic cells.
Tomida M; Heike T; Yokota T
Blood; 1999 Mar; 93(6):1934-41. PubMed ID: 10068666
[TBL] [Abstract][Full Text] [Related]
25. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
Underhill-Day N; Heath JK
Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
[TBL] [Abstract][Full Text] [Related]
26. Expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha, and gp130) in human peripheral neuropathies.
Ito Y; Yamamoto M; Mitsuma N; Li M; Hattori N; Sobue G
Neurochem Res; 2001 Jan; 26(1):51-8. PubMed ID: 11358282
[TBL] [Abstract][Full Text] [Related]
27. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
[TBL] [Abstract][Full Text] [Related]
28. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
[TBL] [Abstract][Full Text] [Related]
29. Cross-reactivity of two human IL-6 family cytokines OSM and LIF explored by protein-protein docking and molecular dynamics simulation.
Du Q; Qian Y; Xue W
Biochim Biophys Acta Gen Subj; 2021 Jul; 1865(7):129907. PubMed ID: 33845142
[TBL] [Abstract][Full Text] [Related]
30. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium.
Aghajanova L; Stavreus-Evers A; Nikas Y; Hovatta O; Landgren BM
Fertil Steril; 2003 Mar; 79 Suppl 1():808-14. PubMed ID: 12620495
[TBL] [Abstract][Full Text] [Related]
31. Lidocaine Suppresses Gastric Cancer Development Through Circ_ANO5/miR-21-5p/LIFR Axis.
Guan E; Liu H; Xu N
Dig Dis Sci; 2022 Jun; 67(6):2244-2256. PubMed ID: 34050852
[TBL] [Abstract][Full Text] [Related]
32. Select HDAC Inhibitors Enhance Osteolysis and Bone Metastasis Outgrowth but Can Be Mitigated With Bisphosphonate Therapy.
Clements ME; Holtslander L; Johnson JR; Johnson RW
JBMR Plus; 2023 Mar; 7(3):e10694. PubMed ID: 36936362
[TBL] [Abstract][Full Text] [Related]
33. The Leukemia Inhibitory Factor Receptor Gene Is a Direct Target of RUNX1.
Qadi AA; Taberlay PC; Phillips JL; Young A; West AC; Brettingham-Moore KH; Dickinson JL; Holloway AF
J Cell Biochem; 2016 Jan; 117(1):49-58. PubMed ID: 26060100
[TBL] [Abstract][Full Text] [Related]
34. Expression of leukaemia inhibitory factor receptor subunits LIFR beta and gp130 in human oocytes and preimplantation embryos.
van Eijk MJ; Mandelbaum J; Salat-Baroux J; Belaisch-Allart J; Plachot M; Junca AM; Mummery CL
Mol Hum Reprod; 1996 May; 2(5):355-60. PubMed ID: 9238703
[TBL] [Abstract][Full Text] [Related]
35. Circ_0003159 upregulates LIFR expression through competitively binding to miR-221-3p/miR-222-3p to block gastric cancer development.
Zheng L; Yan B; Jin G; Han W; Wang H; Wang Z; Ma Y; Nian Y; Meng X; Jiang Z
J Mol Histol; 2022 Apr; 53(2):173-186. PubMed ID: 35034206
[TBL] [Abstract][Full Text] [Related]
36. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
37. DNA methylation controls the responsiveness of hepatoma cells to leukemia inhibitory factor.
Blanchard F; Tracy E; Smith J; Chattopadhyay S; Wang Y; Held WA; Baumann H
Hepatology; 2003 Dec; 38(6):1516-28. PubMed ID: 14647063
[TBL] [Abstract][Full Text] [Related]
38. Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients.
Real SAS; Parveen F; Rehman AU; Shaik R; Deo SVS; Husain SA
Mutat Res; 2019 Nov; 816-818():111677. PubMed ID: 31557600
[TBL] [Abstract][Full Text] [Related]
39. Late gestation modulation of fetal glucocorticoid effects requires the receptor for leukemia inhibitory factor: an observational study.
Ware CB; Nelson AM; Liggitt D
Reprod Biol Endocrinol; 2003 May; 1():43. PubMed ID: 12823859
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations.
Rivera-Del Valle N; Cheng T; Irwin ME; Donnella H; Singh MM; Chandra J
Cancer Chemother Pharmacol; 2018 Mar; 81(3):483-495. PubMed ID: 29313067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]